[Bridging between molecular biology and clinical aspect of respiratory tract diseases: discussion].
Saburo Sone(Io Therapeutics (United States)), K. Nakata, Seiji Hayashi, Nobuoki Kono, Soji Kakiuchi(Tokushima Prefectural Central Hospital)
PubMed
July 10, 2003
Cited by 0
Related Papers
Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations
|Cancer Research|2008|642
Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839)
|Human Molecular Genetics|2004|175
The Neuromedin U-Growth Hormone Secretagogue Receptor 1b/Neurotensin Receptor 1 Oncogenic Signaling Pathway as a Therapeutic Target for Lung Cancer
|Cancer Research|2006|134
Plakophilin 3 Oncogene as Prognostic Marker and Therapeutic Target for Lung Cancer
|Cancer Research|2005|124